Neuroimaging of neurodegenerative disease and healthy aging Gemma Salvadó

Publications 2025 (5)

Vila-Castelar C, Akinci M, Palpatzis E, Aguilar-Dominguez P, Operto G, Kollmorgen G, Quijano-Rubio C, Blennow K, Zetterberg H, Falcon C, Fauria K, Gispert JD, Grau-Rivera O, Suarez-Calvet M, Arenaza-Urquijo EM, ALFA study (...,Hernandez-Villamizar F, López D, Lugo F, Marne P, Menchon T, Minguillón C, Sánchez-Benavides G, Shekari M, Vilor N,...). Sex/gender effects of glial reactivity on preclinical Alzheimer's disease pathology. Mol Psychiatr 2025; 30(4): 1430-1439.
Genius P, Calle ML, Rodriguez-Fernandez B, Minguillón C, Cacciaglia R, Garrido D, Esteller M, Navarro A, Gispert JD, Vilor N^*, Alzheimer's Disease Neuroimaging Initiative; ALFA study. Compositional brain scores capture Alzheimer's disease-specific structural brain patterns along the disease continuum. Alzheimers Dement 2025; 21(2): e14490.
Cacciaglia R, Falcón C, Sánchez-Benavides G, Brugulat-Serrat A, Milà M, Suarez-Calvet M, Molinuevo JL, Fauria K, Minguillón C, Kollmorgen G, Quijano-Rubio C, Blennow K, Zetterberg H, Lorenzini L, Wink AM, Ingala S, Barkhof F, Ritchie CW, Gispert JD^*, ALFA study. Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest Alzheimer's continuum: Evidence across two independent cohorts. Alzheimers Dement 2025; 21(2): e14415.
Cacciaglia R^*, Shekari M, SALVADÓ G, Milà M, Falcón C, Sánchez-Benavides G, Minguillón C, Fauria K, Grau-Rivera O, Molinuevo JL, Blennow K, Zetterberg H, Quevenco FC, Suarez-Calvet M, Gispert JD, ALFA Study. The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease. Brain Commun . 2025; 7(1): fcae451 (Acceptat).
Collij LE^*, Bischof GN, Altomare D, Bader I, Battle M, Vallez-Garcia D, Lopes I, Wolz R, Gismondi R, Stephens A, Walker Z, Scheltens P, Nordberg A, Gispert JD, Drzezga A, Perissinotti A, Morbelli S, Buckley C, Garibotto V, Frisoni GB, Farrar G, Barkhof F, AMYPAD Consortium. Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study. J Nucl Med 2025; 66(1): 110-116.